Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience-Reference-Cited by-同舟云学术

Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience

Published:2020-10 Issue:5 Volume:18 Page:387-394
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Iyer Gopa^ORCID,Tully Christopher M.,Zabor Emily C.,Bochner Bernard H.^ORCID,Dalbagni Guido,Herr Harry W.,Donat S. Machelle,Russo Paul^ORCID,Ostrovnaya Irina,Regazzi Ashley M.,Milowsky Matthew I.,Rosenberg Jonathan E.,Bajorin Dean F.

Funder

National Institutes of Health

The Zena and Michael A. Wiener Research and Therapeutic Program

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference31 articles.

1. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients;Stein;J Clin Oncol,2001

2. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003

3. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration;Eur Urol,2005

4. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial;Griffiths;J Clin Oncol,2011

5. Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer;Zargar;Eur Urol,2015

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant gemcitabine–cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial;Nature Cancer;2024-09-10

2. Clinical Upstaging After Neoadjuvant Chemotherapy Impacting Eligibility for Vaginal-sparing Cystectomy: Identifying Bladder Cancer Patients Who May Benefit From Interim Imaging;Urology;2024-09

3. Predicting response to cisplatin-based neoadjuvant chemotherapy for muscle-invasive bladder cancer: transcriptomic features outrank genomic biomarkers;2024-06-28

4. Effectiveness of dose‐dense methotrexate, vinblastine, doxorubicin, and cisplatin as compared to gemcitabine‐based regimens as neoadjuvant chemotherapy for oncologic outcomes in muscle‐invasive bladder cancer cases—Single‐center study in Japan;International Journal of Urology;2024-05-31

5. Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer;JCO Precision Oncology;2024-04